Prescribing selective serotonin reuptake inhibitors in older age

Maturitas

Volumn 77, Issue 2, 2014, Pages 118-123

  Topiwala, Anya ^a   Chouliaras, Leonidas ^a   Ebmeier, Klaus P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antidepressants; Major depressive disorder; Randomized controlled trials; Risks; Side effects; Suicide

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AKATHISIA; ANOREXIA; ANXIETY DISORDER; BRADYCARDIA; CARDIOTOXICITY; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; EXTRAPYRAMIDAL SYMPTOM; FALLING; FRACTURE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; LETHARGY; NAUSEA; NAUSEA AND VOMITING; NEUROLEPTIC MALIGNANT SYNDROME; OSTEOLYSIS; PRESCRIPTION; RELAPSE; REVIEW; SENESCENCE; SEROTONIN SYNDROME; SLEEP DISORDER; SWEAT GLAND DISEASE; SWEATING; TREMOR; XEROSTOMIA;

ANTIDEPRESSANTS; CGI; CI; CLINICAL GLOBAL IMPRESSION (SCALE); CONFIDENCE INTERVAL; CYP219; CYTOCHROME P450 2C19; EPSE; EXTRAPYRAMIDAL SIDE EFFECTS; FDA; HAM-D; HAMILTON DEPRESSION RATING SCALE; MADRS; MAJOR DEPRESSIVE DISORDER; MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY; MHRA; MONTGOMERY-ÅSBERG DEPRESSION RATING SCALE; NNT; NUMBERS NEEDED TO TREAT; ODDS RATIO; OR; PPIS; PROTON PUMP INHIBITORS; QT INTERVAL CORRECTED (FOR HEART RATE); QTC; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIALS; RCT; RISK RATIO; RISKS; RR; SEROTONIN REUPTAKE INHIBITOR(S); SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR(S); SIDE EFFECTS; SNRI (S); SSRI(S); SUICIDE; TCA(S); TRICYCLIC ANTIDEPRESSANTS(S); US FOOD AND DRUG ADMINISTRATION;

AGED; DEPRESSION; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 84893693477     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.11.006     Document Type: Review

References (78)

1. T.W. Meeks, I.V. Vahia, H. Lavretsky, G. Kulkarni, and D.V. Jeste A tune in "a minor" can "b major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults J Affect Disord 129 1-3 2011 126 142
2. C. Martinez, S. Rietbrock, and L. Wise et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study BMJ 330 7488 2005 389 [Epub 19 February 2005]
3. R.M. Kok, W.A. Nolen, and T.J. Heeren Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants J Affect Disord 141 2-3 2012 103 115
4. R.D. Gibbons, K. Hur, C.H. Brown, J.M. Davis, and J.J. Mann Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine Arch Gen Psychiatry 69 6 2012 572 579
5. B. Arroll, C.R. Elley, and T. Fishman et al. Antidepressants versus placebo for depression in primary care Cochrane Database Syst Rev 3 2009 CD007954
6. M.J. Taylor, N. Freemantle, J.R. Geddes, and Z. Bhagwagar Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis Arch Gen Psychiatry 63 11 2006 1217 1223
7. J.C. Nelson, K. Delucchi, and L.S. Schneider Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence Am J Geriatr Psychiatry 16 7 2008 558 567
8. R. Calati, M. Salvina Signorelli, and M. Balestri et al. Antidepressants in elderly: metaregression of double-blind, randomized clinical trials J Affect Disord 147 1-3 2013 1 8
9. G.D. Tollefson, J.C. Bosomworth, J.H. Heiligenstein, J.H. Potvin, and S. Holman A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The fluoxetine collaborative study group Int Psychogeriatr 7 1 1995 89 104
10. S. Kasper, H. de Swart, and H. Friis Andersen Escitalopram in the treatment of depressed elderly patients Am J Geriatr Psychiatry 13 10 2005 884 891
11. A. Schatzberg, and S. Roose A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression Am J Geriatr Psychiatry 14 4 2006 361 370
12. M. Evans, M. Hammond, K. Wilson, M. Lye, and J. Copeland Placebo-controlled treatment trial of depression in elderly physically ill patients Int J Geriatr Psychiatry 12 8 1997 817 824
13. M.H. Rapaport, L.S. Schneider, D.L. Dunner, J.T. Davies, and C.D. Pitts Efficacy of controlled-release paroxetine in the treatment of late-life depression J Clin Psychiatry 64 9 2003 1065 1074
14. A. Bose, D. Li, and C. Gandhi Escitalopram in the acute treatment of depressed patients aged 60 years or older Am J Geriatr Psychiatry 16 1 2008 14 20
15. S.P. Roose, H.A. Sackeim, and K.R. Krishnan et al. Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial Am J Psychiatry 161 11 2004 2050 2059
16. L.S. Schneider, J.C. Nelson, and C.M. Clary et al. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression Am J Psychiatry 160 7 2003 1277 1285
17. J.S. Wakelin Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data Int Clin Psychopharmacol 1 3 1986 221 230
18. D. Taylor, N. Meader, and V. Bird et al. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy Br J Psychiatry 198 3 2011 179 188
19. S. Banerjee, J. Hellier, and R. Romeo et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine Health Technol Assess 17 7 2013 1 166
20. A.L. Nyth, C.G. Gottfries, and K. Lyby et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia Acta Psychiatr Scand 86 2 1992 138 145
21. C.A. Munro, C.F. Longmire, and L.T. Drye et al. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease Am J Geriatr Psychiatry 20 12 2012 1036 1044
22. Forlenza, Stoppe, Hirara, and Ferrier Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients Sao Paulo Med J 18 4 1991 99 104
23. E. Guillibert, Y. Pelicier, and J.C. Archambault et al. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients Acta Psychiatr Scand Suppl 350 1989 132 134
24. C.J. Kyle, H.E. Petersen, and K.F. Overø Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice Depress Anxiety 8 4 1998 147 153
25. P.M. Wehmeier, M. Kluge, and A. Maras et al. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients Pharmacopsychiatry 38 1 2005 13 16
26. W. Bondareff, M. Alpert, A.J. Friedhoff, E.M. Richter, C.M. Clary, and E. Batzar Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life Am J Psychiatry 157 5 2000 729 736
27. M.E. Culang-Reinlieb, J.R. Sneed, J.G. Keilp, and S.P. Roose Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline Int J Geriatr Psychiatry 27 8 2012 777 784
28. K. Demyttenaere, E. Corruble, A. Hale, M.A. Quera-Salva, F. Picarel-Blanchot, and S. Kasper A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline CNS Spectr 18 3 2013 163 170
29. W.E. Falk, J.F. Rosenbaum, M.W. Otto, P.M. Zusky, J.B. Weilburg, and R.A. Nixon Fluoxetine versus trazodone in depressed geriatric patients J Geriatr Psychiatry Neurol 2 4 1989 208 214
30. J.D. Guelfi, M. Bouhassira, E. Bonett-Perrin, and S. Lancrenon The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice Encephale 25 3 1999 265 270
31. J. Bocksberger, R.C. Young, and T. Kakuma Age at onset and treatment of geriatric depression Neuropsychopharmacology 11 4 1994 266
32. P. Allard, L. Gram, K. Timdahl, K. Behnke, M. Hanson, and J. Søgaard Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram Int J Geriatr Psychiatry 19 12 2004 1123 1130
33. K.L. Weihs, E.C. Settle, S.R. Batey, T.L. Houser, R.M. Donahue, and J.A. Ascher Bupropion sustained release versus paroxetine for the treatment of depression in the elderly J Clin Psychiatry 61 3 2000 196 202
34. T. Dorman Sleep and paroxetine: a comparison with mianserin in elderly depressed patients Int Clin Psychopharmacol 6 Suppl 4 1992 53 58
35. J. Daléry, and V. Aubin Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence Encephale 27 1 2001 71 81
36. P. Wilkinson, and Z. Izmeth Continuation and maintenance treatments for depression in older people Cochrane Database Syst Rev 11 2012 CD006727
37. P. Gorwood, E. Weiller, O. Lemming, and C. Katona Escitalopram prevents relapse in older patients with major depressive disorder Am J Geriatr Psychiatry 15 7 2007 581 593
38. R. Klysner, J. Bent-Hansen, and H.L. Hansen et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy Br J Psychiatry 181 2002 29 35
39. K.C. Wilson, P.G. Mottram, L. Ashworth, and M.T. Abou-Saleh Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study Br J Psychiatry 182 2003 492 497
40. J.M. Ferguson SSRI antidepressant medications: adverse effects and tolerability Prim Care Companion J Clin Psychiatry 3 1 2001 22 27 [Epub 12 March 2004]
41. D.W. Oslin, T.R. Ten Have, and J.E. Streim et al. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents J Clin Psychiatry 64 8 2003 875 882
42. B.H. Mulsant, B.G. Pollock, and R. Nebes et al. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients Am J Geriatr Psychiatry 9 4 2001 406 414 [Epub 12 December 2001]
43. L.D. Garfield, D. Dixon, and P. Nowotny et al. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial Am J Geriatr Psychiatry 2013 [Epub 12 September 2013]
44. D.G. Blazer Depression in late life: review and commentary J Gerontol A Biol Sci Med Sci 58 3 2003 249 265 [Epub 14 March 2003]
45. H. Ragneskog, S. Eriksson, I. Karlsson, and C.G. Gottfries Long-term treatment of elderly individuals with emotional disturbances: an open study with citalopram Int Psychogeriatr 8 4 1996 659 668 [Epub 1 January 1996]
46. K. Wilson, and P. Mottram A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis Int J Geriatr Psychiatry 19 8 2004 754 762 [Epub 4 August 2004]
47. Y. Barak, M. Swartz, D. Levy, and R. Weizman Age-related differences in the side effect profile of citalopram Prog Neuropsychopharmacol Biol Psychiatry 27 3 2003 545 548 [Epub 15 April 2003]
48. T.J. Wilkinson, E.J. Begg, A.C. Winter, and R. Sainsbury Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people Br J Clin Pharmacol 47 2 1999 211 217 [Epub 6 April 1999]
49. V. Kirchner, L.E. Silver, and C.A. Kelly Selective serotonin reuptake inhibitors and hyponatraemia: review and proposed mechanisms in the elderly J Psychopharmacol 12 4 1998 396 400 [Epub 5 March 1999]
50. D. Kirby, S. Harrigan, and D. Ames Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit Int J Geriatr Psychiatry 17 3 2002 231 237 [Epub 29 March 2002]
51. Y.I. Sheline, K.E. Freedland, and R.M. Carney How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? Am J Med 102 1 1997 54 59 [Epub 1 January 1997]
52. K.P. Padala, P.R. Padala, and S.P. Wengel Dose-dependent bradycardia with citalopram in an elderly patient Prim Care Companion J Clin Psychiatry 12 1 2010 [PCC09100789; Epub 29 June 2010]
53. M.J. Cooke, and W.S. Waring Citalopram and cardiac toxicity Eur J Clin Pharmacol 69 4 2013 755 760 [Epub 22 September 2012]
54. K. Zivin, P.N. Pfeiffer, and A.S. Bohnert et al. Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg Am J Psychiatry 170 6 2013 642 650 [Epub 4 May 2013]
55. M. Dall, O.B. Schaffalitzky de Muckadell, A.T. Lassen, J.M. Hansen, and J. Hallas An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding Clin Gastroenterol Hepatol 7 12 2009 1314 1321 [Epub 1 September 2009]
56. F.J. de Abajo, and L.A. Garcia-Rodriguez Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents Arch Gen Psychiatry 65 7 2008 795 803 [Epub 9 July 2008]
57. F.J. de Abajo, L.A. Rodriguez, and D. Montero Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study BMJ 319 7217 1999 1106 1109 [Epub 26 October 1999]
58. L.E. Targownik, J.M. Bolton, C.J. Metge, S. Leung, and J. Sareen Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding Am J Gastroenterol 104 6 2009 1475 1482 [Epub 6 June 2009]
59. V.L. Serebruany, A.H. Glassman, and A.I. Malinin et al. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin Eur J Heart Fail 5 4 2003 517 521 [Epub 19 August 2003]
60. M. Dall, O.B. Schaffalitzky de Muckadell, A.T. Lassen, and J. Hallas There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study Aliment Pharmacol Ther 32 11-12 2010 1383 1391 [Epub 6 November 2010]
61. M. Dall, O.B. Schaffalitzky de Muckadell, J. Moller Hansen, M. Wildner-Christensen, A. Touborg Lassen, and J. Hallas Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors Scand J Gastroenterol 46 9 2011 1039 1044 [Epub 11 May 2011]
62. A. Carvajal, S. Ortega, and L. Del Olmo et al. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study PLoS One 6 5 2011 e19819 [Epub 1 June 2011]
63. X. Vidal, L. Ibanez, L. Vendrell, A. Conforti, and J.R. Laporte Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study Drug Saf 31 2 2008 159 168 [Epub 26 January 2008]
64. Y. Yuan, K. Tsoi, and R.H. Hunt Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 119 9 2006 719 727 [Epub 2 September 2006]
65. R.M. Weinrieb, M. Auriacombe, K.G. Lynch, K.M. Chang, and J.D. Lewis A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients J Clin Psychiatry 64 12 2003 1502 1510 [Epub 20 January 2004]
66. B. Liu, G. Anderson, N. Mittmann, T. To, T. Axcell, and N. Shear Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people Lancet 351 9112 1998 1303 1307 [Epub 27 June 1998]
67. P.B. Thapa, P. Gideon, T.W. Cost, A.B. Milam, and W.A. Ray Antidepressants and the risk of falls among nursing home residents N Engl J Med 339 13 1998 875 882 [Epub 24 September 1998]
68. V. Rabenda, D. Nicolet, C. Beaudart, O. Bruyere, and J.Y. Reginster Relationship between use of antidepressants and risk of fractures: a meta-analysis Osteoporos Int 24 1 2013 121 137 [Epub 29 May 2012]
69. S.J. Diem, K. Ruppert, and J.A. Cauley et al. Rates of bone loss among women initiating antidepressant medication use in midlife J Clin Endocrinol Metab 98 11 2013 4355 4363 [Epub 5 September 2013]
70. P.K. Gillman The serotonin syndrome N Engl J Med 352 23 2005 2454 2456 [author reply-6; Epub 11 June 2005]
71. R.M. Lane SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment J Psychopharmacol 12 2 1998 192 214 [Epub 7 August 1998]
72. N. Gormley, L. Watters, and B. Lawlor Extrapyramidal side-effects in elderly patients exposed to selective serotonin reuptake inhibitors Human Psychopharmacol 12 1997 139 143
73. J.E. Desmarais, and K.J. Looper Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions Maturitas 67 4 2010 296 308 [Epub 1 October 2010]
74. J.R. Fann, A.M. Thomas-Rich, and W.J. Katon et al. Major depression after breast cancer: a review of epidemiology and treatment Gen Hosp Psychiatry 30 2 2008 112 126 [Epub 23 February 2008]
75. C.M. Kelly, D.N. Juurlink, and T. Gomes et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study BMJ 340 2010 c693 [Epub 10 February 2010]
76. T.L. Lash, D. Cronin-Fenton, and T.P. Ahern et al. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen Acta Oncol 49 3 2010 305 312 [Epub 17 February 2010]
77. P.S. Masand, and S. Gupta Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine Ann Clin Psychiatry 14 3 2002 175 182 [Epub 15 February 2003]
78. R.C. Rosen, R.M. Lane, and M. Menza Effects of SSRIs on sexual function: a critical review J Clin Psychopharmacol 19 1 1999 67 85 [Epub 6 February 1999]